Patients with acute hepatic porphyria are denied essential operations because of concern that general anaesthesia and surgery will precipitate a life threatening porphyric crisis. This study assessed the safety of surgery under general anaesthesia in these patients. A combined prospective and retrospective case note study, with a biochemical study, was conducted in 25 patients with acute hepatic porphyria undergoing 38 Because the porphyrias are a group of metabolic liver diseases characterised by episodic abdominal pain, many of these patients and their families are under the care of gastroenterologists, hepatologists or surgeons. Because they are rare diseases, few such physicians have wide experience of their treatment, and therefore guidelines from specialist centres are particularly important.
The acute hepatic porphyrias are a group of inherited metabolic disorders of the haem biosynthetic pathway.' The cardinal feature of these diseases is the development of acute crises, which have an appreciable mortality. Episodes are characterised by severe abdominal pain, paralysis, seizures, hypertension, and tachycardia. During the porphyric episode, there is overproduction and increased urinary excretion of the haem precursors formed proximal to the metabolic block -that is, 8 amino laevulinic acid (ALA) and porphobilinogen (PBG). The activity of the porphyria can be assessed by measuring their 24 hour urinary excretion.
Because the porphyrias are a group of metabolic liver diseases characterised by episodic abdominal pain, many of these patients and their families are under the care of gastroenterologists, hepatologists or surgeons. Because they are rare diseases, few such physicians have wide experience of their treatment, and therefore guidelines from specialist centres are particularly important.
Acute porphyric crises can be precipitated by a variety of factors including certain drugs, starvation, infection, and metabolic stress.2
These factors come together at the time of a surgical operation. Patients with acute hepatic porphyria may thus be denied surgical treatment for coexisting diseases, because of fear of precipitating a life threatening porphyric crisis.
We have been aware of patients with porphyria undergoing major surgery without complication, of others having a crisis after minor surgery, and also of surgeons denying essential surgery to patients because of porphyria. This has prompted us to review the surgical experiences of our patients to try and identify risk factors and suggest guidelines for safe anaesthesia and surgery in acute hepatic porphyria.
Methods
This was a combined retrospective and prospective study. For the retrospective part, case records were reviewed and patients interviewed to identify previous surgical operations before or after the diagnosis of porphyria was made. Attempts were then made to obtain the hospital records including operation and anaesthetic notes and details of any postoperative problem.
For the prospective part we studied eight known porphyric patients undergoing a variety of operations. In five of these cases it was possible to assess the activity of their porphyria perioperatively by monitoring the 24 hour urinary excretion of porphyrin precursors. Urinary ALA and PBG concentrations were measured by spectrophotometric assay.3
Results
Altogether 38 surgical operations were identified among 25 patients (18 women (Table I ). In all of these patients anaesthetics and perioperative drugs believed to be unsafe in porphyria were avoided. of a sustained rise in markers of disease activity over preoperative values. The transient rises in ALA or PBG that were seen in three patients were not associated with clinical evidence of disease activity. They may represent subclinical disease activity, associated with some aspect of the operation, for example, drugs, starvation, stress, etc.4 Alternatively these rises may not truly be reflecting disease activity, perhaps resulting from increased haem synthesis due to blood loss, or a consequence of blood transfusion.5
This study also confirms that provided the necessary precautions are taken patients with porphyria can safely undergo even the most major surgery, for example heart valve replacement, coronary artery grafting, and hip replacement. 6 7 Propofol was the most commonly used intravenous anaesthetic agent, confirming a previous prospective study of its safety in varieagate porphyria.8 There is, however, a report of biochemical activation of porphyria after propofol administration.9 The choice of drugs and anaesthetics used in the patients known to Moreover, in retrospect, it seems probable that seven of these nine operations were undertaken for symptoms of porphyria. These operations, where the diagnosis was unknown and the disease was active, were particularly hazardous; with two fatal and two non-fatal crises, and only one patient recovering without complication, twice. This is similar to previous reported experience, '7 where all seven patients given thiopental to induce anaesthesia during an acute symptomatic episode of porphyria worsened biochemically and clinically.
Because acute porphyria is an uncommon disease, which can mimic other conditions, it is likely to have caused other undiagnosed postoperative deaths and morbidity. Patients with porphyria need appropriate treatment when they develop a true abdominal surgical emergency, though this can be difficult to diagnose. 18 Three patients had operations before the diagnosis was made, and further surgery afterwards. The prediagnosis operations were minor (two appendicectomies and one ovarian cystectomy) compared with the postdiagnosis operations (total hysterectomy, cholecystectomy, and renal transplant). Nevertheless, these patients each had a porphyric crisis as a result of the anaesthetic and minor operation undertaken before diagnosis, but had no complications of porphyria after operations when they were known to be porphyric, and thus received only safe agents.
The problem of patients being denied surgery because of porphyria is exemplified by patient 14. Her original surgeon and his anaesthetist would not undertake lumpectomy for a small breast tumour. She could not be given endocrine treatment because of its porphyrinogenicity. 14 Eighteen months later she re-presented with extensive local disease requiring mastectomy and axillary clearance for cosmesis and local control. She later died of metastatic disease. This outcome may have been avoided by earlier and less mutilating surgery.
In conclusion, this study shows that even major and repeated surgery can be performed without complication in patients with acute hepatic porphyria. Safety depends upon a knowledge of the diagnosis and which anaesthetic agents are safe. The risk is for undiagnosed cases, and continued awareness of the features of this disease is required to prevent crises and deaths.
